Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

4.5%

53 terminated/withdrawn out of 1180 trials

Success Rate

91.3%

+4.7% vs industry average

Late-Stage Pipeline

14%

165 trials in Phase 3/4

Results Transparency

4%

21 of 554 completed trials have results

Key Signals

135 recruiting21 with results31 terminated22 withdrawn

Enrollment Performance

Analytics

N/A
375(46.0%)
Phase 2
235(28.8%)
Phase 4
93(11.4%)
Phase 3
72(8.8%)
Phase 1
39(4.8%)
Early Phase 1
2(0.2%)
816Total
N/A(375)
Phase 2(235)
Phase 4(93)
Phase 3(72)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1180)

Showing 20 of 1180 trials
NCT07852637Phase 4Not Yet Recruiting

Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism

Role: lead

NCT07629297Recruiting

A Korean Point Prevalence Study of Acute Rehabilitation for Kids in the PICU (PARK-PICU)

Role: lead

NCT07824531Active Not Recruiting

Feasibility of Vision-Language Models for Detecting Physical Assistance as an Observable Criterion Defining GMFCS Levels in Children Aged 2 to 6 Years With Cerebral Palsy

Role: lead

NCT07821307Phase 2Completed

Opiranserin Injections PCA Regimens for Postoperative Pain

Role: lead

NCT07638176Not ApplicableRecruiting

Effect of Individualized Positive End-expiratory Pressure (PEEP) in Patients Who Have an Intrinsic PEEP During One-lung Ventilation

Role: lead

NCT07806994Not ApplicableRecruiting

Wearable Eye Tracking During Bimanual Tasks in Children With Cerebral Palsy

Role: lead

NCT07803081Recruiting

Radiotherapy and Long-term Outcomes in Early Breast Cancer With SLNB Omission

Role: lead

NCT07793916Recruiting

3D Transthoracic Echocardiographic Evaluation on Tricuspid Regurgitation Progression and Clinical Outcomes in Patients With Cardiac Implantable Electronic Device

Role: lead

NCT07772804Not ApplicableNot Yet Recruiting

Effect of Mechanical Power-based Lung-protective Ventilation During One-lung Ventilation

Role: lead

NCT07783932Not ApplicableRecruiting

Comparing the Effectiveness of Large Language Model-Based and Video-Based Refresher Education on Knowledge Retention After Simulation-Based Pediatric Cardiopulmonary Resuscitation Training: A Six-Month Follow-Up Study

Role: lead

NCT07783984Not ApplicableRecruiting

Thoracoscopic Versus Catheter Ablation in Persistent Atrial Fibrillation With Enlarged Left Atrium

Role: lead

NCT07755605Not ApplicableRecruiting

Digital Therapeutics for Social Cognitive Function in Schizophrenia Spectrum Disorder

Role: lead

NCT07776054Phase 4Recruiting

Clinical Impact of SGLT2 Inhibitor After DC Cardioversion in Persistent AF With HFpEF

Role: lead

NCT05507749Not ApplicableActive Not Recruiting

Cyroablation for Pulmonary Vein Isolation Alone in Patients With Early Persistent AF Assessed by Continuous Monitoring

Role: collaborator

NCT07774520Phase 2Recruiting

A Randomized Study to Evaluate the Efficacy of a Reduced Starting Dose of Lazertinib (Leclaza) and Preemtive Magnesium Supplementation to Prevent Lazertinib(Leclaza)-Induced Peripheral Neuropathy

Role: lead

NCT02688894Recruiting

The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]

Role: lead

NCT03578185Recruiting

Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy

Role: lead

NCT07757958Phase 3Not Yet Recruiting

Partial Breast Irradiation Without Sentinel Lymph Node Biopsy in Low-Risk Early Breast Cancer

Role: lead

NCT05893966Recruiting

Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer

Role: lead

NCT05775757Active Not Recruiting

SMC Radiation Oncology Breast Cancer Cohort Study

Role: lead